Editorial
doi: 10.2217/pgs-2018-0191.
Epub 2019 Feb 27.
The future of pharmacogenetics in the treatment of hypertension
Affiliations
- PMID: 30808251
- DOI: 10.2217/pgs-2018-0191
Item in Clipboard
Editorial
The future of pharmacogenetics in the treatment of hypertension
Pharmacogenomics.
2019 Feb.
No abstract available
Keywords: beta blocker; blood pressure; calcium channel blocker; pharmacogenomics; single nucleotide polymorphism; thiazide.
Similar articles
-
G protein receptor kinase 4 polymorphisms: β-blocker pharmacogenetics and treatment-related outcomes in hypertension.Hypertension. 2012 Oct;60(4):957-64. doi: 10.1161/HYPERTENSIONAHA.112.198721. Epub 2012 Sep 4. Hypertension. 2012. PMID: 22949529 Free PMC article.
-
Commentary on the management of elevated blood pressure in pregnancy.J Clin Hypertens (Greenwich). 2009 May;11(5):289-91. doi: 10.1111/j.1751-7176.2009.00127.x. J Clin Hypertens (Greenwich). 2009. PMID: 19490287 Free PMC article. No abstract available.
-
Genetic variation in the beta2 subunit of the voltage-gated calcium channel and pharmacogenetic association with adverse cardiovascular outcomes in the INternational VErapamil SR-Trandolapril STudy GENEtic Substudy (INVEST-GENES).Circ Cardiovasc Genet. 2010 Dec;3(6):548-55. doi: 10.1161/CIRCGENETICS.110.957654. Circ Cardiovasc Genet. 2010. PMID: 21156931 Free PMC article. Clinical Trial.
-
[Antihypertensive medication and sleep].Dtsch Med Wochenschr. 1998 Nov 13;123(46):1389-94. doi: 10.1055/s-2007-1024193. Dtsch Med Wochenschr. 1998. PMID: 9842400 Review. German. No abstract available.
-
[Treatment of myocardial ischemia with reference to blood pressure values].Cardiology. 1993;82 Suppl 2:58-65. doi: 10.1159/000175918. Cardiology. 1993. PMID: 8100187 Review. German. No abstract available.
Cited by
-
No Association Between AGT Gene Polymorphisms with Hypertension in a South African Population.Diabetes Metab Syndr Obes. 2024 Apr 29;17:1853-1865. doi: 10.2147/DMSO.S452272. eCollection 2024. Diabetes Metab Syndr Obes. 2024. PMID: 38706806 Free PMC article.
-
Pharmacogenomics And Hypertension: Current Insights.Pharmgenomics Pers Med. 2019 Nov 22;12:341-359. doi: 10.2147/PGPM.S230201. eCollection 2019. Pharmgenomics Pers Med. 2019. PMID: 31819590 Free PMC article. Review.
-
Pharmacogenetic and microRNA mechanisms of beta blocker use on bone.J Bone Miner Res. 2025 Feb 2;40(2):231-240. doi: 10.1093/jbmr/zjae200. J Bone Miner Res. 2025. PMID: 39673185 Clinical Trial.
-
Current concepts and molecular mechanisms in pharmacogenetics of essential hypertension.Indian J Pharmacol. 2021 Jul-Aug;53(4):301-309. doi: 10.4103/ijp.IJP_593_19. Indian J Pharmacol. 2021. PMID: 34414909 Free PMC article. Review.
-
Influence of CYP2D6 and CYP3A5 Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Bisoprolol in Hypertensive Chinese Patients.Front Med (Lausanne). 2021 Sep 9;8:683498. doi: 10.3389/fmed.2021.683498. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34568359 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
